INSIGHTS ON DRUG DEVELOPMENT

• Expanding Opportunities For Inhaled Drug Delivery

  Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.

• Little Patients, Big Challenges: Developing Pediatric Formulations

  Explore the development of high-quality, child-friendly oral formulations, as well as learn about new testing requirements for impurities and innovative approaches to creating age-appropriate medications.

• Right From The Start: Smarter Developability For Stronger Formulations

  Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.

• Target Product Profile (TPP) Explained

  Learn how to best align your development strategy, guide cross-functional decisions, and build a clear pathway from discovery to successful commercialization.

• The Role Of A Consulting Firm In The IND Process

  6/10/2025

  Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.

• Advancing GLP-1 Analog Drug Development Using A Variety Of Techniques

  6/27/2025

  Discover how SEC-MALS reveals the aggregation behavior of GLP-1 analogs like semaglutide and liraglutide, which are critical for ensuring the stability, efficacy, and safety of peptide therapeutics.

• Cost And Scalability Key Drivers Of Expanded Gene Therapy Access

  5/16/2025

  Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.

• Robust Database Characterizes And Optimizes Product Development

  8/29/2026

  Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.

• Overcome Early Development Challenges Before They Impact Your Program

  9/3/2026

  Poor manufacturability and immunogenicity can delay development. Learn how early developability assessments support IND readiness.